Dose Response Trial of Pergolide for Cocaine Dependence - 1 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

September 1, 2005

Start Date ^ICMJE

February 1996

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Side effects
Drug use
Retention
Cocaine withdrawal
Compliance
Effectiveness of medication for global improvements

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00000248 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Dose Response Trial of Pergolide for Cocaine Dependence - 1

Official Title ^ICMJE

Dose Response Trial of Pergolide for Cocaine Dependence

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Detailed Description

Study Phase

Phase III

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment

Condition ^ICMJE

Cocaine-Related Disorders

Intervention ^ICMJE

Drug: Pergolide

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Please contact site for information.

Gender

Both

Ages

21 Years to 50 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000248

Responsible Party

Study ID Numbers ^ICMJE

NIDA-08355-1, R01-08355-1

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

Medical University of South Carolina

Investigators ^ICMJE

Principal Investigator:

Robert Malcolm, M.D.

Medical University of South Carolina

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

May 1997

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP